The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: current situation

被引:23
|
作者
Martinez-Martinez, Luis [1 ]
Calvo, Jorge [1 ]
机构
[1] Hosp Univ Marques Valdecilla, Microbiol Serv, Santander, Spain
关键词
Enterobacteria; Multiresistance; beta-lactamases; Carbapenems; Pseudomonas aeruginosa; Acinetobacter baumannii;
D O I
10.1016/S0213-005X(10)70027-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Resistance to antimicrobial agents in clinically relevant Gram-negative bacteria is an increasingly important problem, which in the last few years has spread from the hospital setting to the community. In enterobacteria, the main features of this situation include resistance to beta-lactams and quinolones. beta-Lactam resistance is caused by intrinsic beta-lactamases, extended-spectrum beta-lactamases, plasmid-mediated cephamycinases and carbapenemses, particularly when produced in strains with decreased permeability because of altered porin expression. Quinolone resistance is a multifactorial problem in which the importance of plasmid-mediated mechanisms (Qnr proteins, acetylase, active efflux pumps) is being recognized. Several studies in Spain and other countries show that strains with these resistance mechanisms are being isolated with increased frequency. Of particular concern is the spread of Escherichia coli and other species producing extended-spectrum beta-lactamases (most frequently of the CTX-M family), affecting outpatients. Very commonly these mechanisms are simultaneously expressed within the same bacterial host, leading to a multiresistance phenotype. This problem is also of major clinical importance in non-fermenting Gram-negative rods, including Pseudomonas aeruginosa and Acinetobacter baumannii and, to a lesser extent, Stenotrophomonas maltophilia and some other species. Multiresistance in non-fermenting organisms results from the presence of intrinsic mechanisms (production of distinct beta-lactamases, decreased permeability and expression of several active efflux pumps) and from the acquisition of exogenous genes. Therapeutic difficulties reach their maximum when bacteria express resistance to carbapenems (a multifactorial problem) or to polymyxins. New compounds with specific activity against multiresistant Gram-negative rods should be developed, which, together with other measures, would contribute to controlling the current serious situation. (c) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [31] Tigecycline resistance in Australian antibiotic-resistant gram-negative bacteria
    Iredell, Jon
    Thomas, Lee
    Power, Damla
    Mendes, Eulogio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) : 816 - 818
  • [32] Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria
    Luna, Brian M.
    Ershova, Ksenia
    Yan, Jun
    Ulhaq, Amber
    Nielsen, Travis B.
    Hsieh, Sarah
    Pantapalangkoor, Paul
    Vanscoy, Brian
    Ambrose, Paul
    Rudin, Sue
    Hujer, Kristine
    Bonomo, Robert A.
    Actis, Luis
    Skaar, Eric P.
    Spellberg, Brad
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (09) : 2631 - 2639
  • [33] Resistance mechanisms in Gram-negative bacteria
    Lepe, J. A.
    Martinez-Martinez, L.
    MEDICINA INTENSIVA, 2022, 46 (07) : 392 - 402
  • [34] Antibiotic-induced stress responses in Gram-negative bacteria and their role in antibiotic resistance
    Brand, Chante
    Newton-Foot, Mae
    Grobbelaar, Melanie
    Whitelaw, Andrew
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025,
  • [35] Multiple resistance in Gram-negative bacteria
    Hawkey, PM
    Munday, CJ
    REVIEWS IN MEDICAL MICROBIOLOGY, 2004, 15 (02) : 51 - 61
  • [36] New antibiotic hits Gram-negative bacteria
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (11) : 785 - 785
  • [37] Screening for antibiotic resistant Gram-negative bacteria
    Iredell, Jonathan R.
    Sintchenko, Vitali
    LANCET INFECTIOUS DISEASES, 2006, 6 (06): : 316 - 317
  • [38] New antibiotic hits Gram-negative bacteria
    Katie Kingwell
    Nature Reviews Drug Discovery, 2018, 17 : 785 - 785
  • [39] Multidrug resistance in Gram-negative bacteria
    Poole, K
    CURRENT OPINION IN MICROBIOLOGY, 2001, 4 (05) : 500 - 508
  • [40] Resistance in gram-negative bacteria: Enterobacteriaceae
    Paterson, David L.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2006, 34 (05) : S20 - S28